Short answer · Medically reviewed summary · Last updated: 2023-07-13
Argininosuccinic Aciduria (ASA) is a rare genetic disorder that affects the urea cycle, a process responsible for removing toxic ammonia from the body. This condition is caused by a deficiency of the enzyme argininosuccinate lyase, which leads to the accumulation of argininosuccinic acid in the blood. ASA is typically diagnosed in infancy or early childhood, and its severity can vary widely among individuals.
1 people with Argininosuccinic Aciduria have shared their first-person experience on this question at DiseaseMaps.
What is the life expectancy of someone with Argininosuccinic Aciduria?
Life expectancy with Argininosuccinic Aciduria: what research and real patients say, recent advances, and a medically reviewed summary with sources.
Argininosuccinic Aciduria (ASA) is a rare genetic disorder that affects the urea cycle, a process responsible for removing toxic ammonia from the body. This condition is caused by a deficiency of the enzyme argininosuccinate lyase, which leads to the accumulation of argininosuccinic acid in the blood.
ASA is typically diagnosed in infancy or early childhood, and its severity can vary widely among individuals. The symptoms may include poor appetite, vomiting, developmental delays, intellectual disability, seizures, liver dysfunction, and an increased risk of liver cancer.
The life expectancy of individuals with ASA depends on various factors, including the severity of the condition, the age of diagnosis, and the effectiveness of treatment. Early diagnosis and prompt initiation of treatment are crucial in improving outcomes.
Treatment for ASA primarily involves a low-protein diet and the supplementation of specific amino acids to help manage ammonia levels. In some cases, individuals may require medications to enhance ammonia detoxification or liver transplantation if liver function becomes severely compromised.
With appropriate management, individuals with ASA can lead relatively normal lives. However, the long-term prognosis can still be challenging. Some individuals may experience recurrent episodes of hyperammonemia, which can be life-threatening if not promptly treated. The risk of liver complications, such as cirrhosis or liver cancer, may also impact life expectancy.
It is important for individuals with ASA to receive ongoing medical care and monitoring to ensure early detection and management of any potential complications. Regular follow-ups with metabolic specialists, dietitians, and other healthcare professionals are essential to optimize treatment and support overall well-being.
In conclusion, the life expectancy of someone with Argininosuccinic Aciduria can vary depending on the individual and the severity of the condition. Early diagnosis, appropriate treatment, and ongoing medical care are crucial in improving outcomes and maximizing life expectancy.
Posted Oct 24, 2019 by Mark 700
